Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
干扰素α对鼠丙型疱疹病毒潜伏期的调节
基本信息
- 批准号:8648978
- 负责人:
- 金额:$ 36.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAntiviral AgentsAntiviral ResponseB-LymphocytesBindingBiochemical GeneticsBiological AssayBurkitt LymphomaCell LineCellsChronicDataDrug usageElementsEventFamilyGene ExpressionGenesGeneticGenomeHerpesviridaeHerpesviridae InfectionsHumanHuman Herpesvirus 4Human Herpesvirus 8Human VirusIFNAR1 geneImmuneImmune responseImmunocompromised HostIn VitroInfectionInflammatoryInterferon ReceptorInterferon Type IInterferon-alphaInterferonsKaposi SarcomaLeadLife Cycle StagesModelingMurine herpesvirus 68MusNatureOncogenesOncogenicPathologicPathway interactionsPhysiologicalPlayProcessProteinsRegulationReporterResearchResponse ElementsRoleSignal PathwaySignal TransductionStimulusSystemTestingTimeTissuesTranscriptTransgenesViralViral GenesViral GenomeViral PhysiologyVirusVirus DiseasesVirus LatencyVirus ReplicationWorkbasecancer therapycytokinegammaherpesvirusin vivoinfected B cellinsightlatent gene expressionlatent infectionlytic replicationmacrophagemortalitymutantnovelpathogenpreventpromoterpublic health relevancereactivation from latencyrecombinaseresponsetherapeutic targettranscription factor
项目摘要
DESCRIPTION (provided by applicant): The type I interferon (IFN) cytokine family comprises the first line of innate defense against virus infections. Mice lacking the IFN receptor (IFNAR1-/-) display high-level virus replication and increased mortality, demonstrating a critical role for IFN in host response to virus infection. However, prevailing models of IFN function assume that these cytokines function solely during acute infection and are dispensable once the adaptive immune response has silenced viral replication. Relatively little is known about potential functions of IFN during chronic or latent infection. We found unexpectedly that IFN prevents reactivation of murine -herpesvirus 68 (MHV68) during latency in vivo. MHV68 is a natural pathogen of mice and displays genetic and pathologic similarities to the human ?-herpesviruses Epstein-Barr virus and Kaposi Sarcoma herpesvirus. The effects of IFN during MHV68 latency did not require the most well characterized IFN-stimulated antiviral genes, which prompted us to consider a novel mechanism. Indeed, our preliminary data show that IFN directly regulates MHV68 latent gene expression via the binding of cellular interferon regulatory factors (IRFs) to viral promoters in latently-infected B cells. This suggests the intriguing hypothesis that -herpesviruses have evolved to integrate their gene expression circuitry with IFN signaling pathways, thereby co-opting a host antiviral system to promote strategic timing of reactivation during periods of immunocompromise. The proposed research uses the tractable MHV68 system to identify the physiologic roles of IFN in regulating viral latent gene expression and reactivation in vivo. Three Specific Aims are proposed to: (i) test the hypothesis that IFN regulates MHV68 infection by acting directly on the infected cell during latency; (ii) identify interferon-regulated viral promoter elements that control replication, gene expression, and reactivation and (iii) define the mechanism by which IRFs regulate latent viral gene expression and reactivation. This research will have broad significance for understanding IFN function during chronic infections and will lead to the identification of host antiviral pathways that may prove relevant for control of oncogenic human??-herpesviruses.
描述(由申请人提供):I型干扰素(IFN)细胞因子家族包括抗病毒感染的第一道先天防御。缺乏IFN受体(IFNAR 1-/-)的小鼠显示高水平的病毒复制和增加的死亡率,表明IFN在宿主对病毒感染的反应中起关键作用。然而,IFN功能的流行模型假设这些细胞因子仅在急性感染期间起作用,并且一旦适应性免疫应答使病毒复制沉默,这些细胞因子就被抑制。关于IFN在慢性或潜伏感染中的潜在功能知之甚少。我们意外地发现IFN在体内潜伏期期间阻止鼠疱疹病毒68(MHV 68)的再活化。MHV 68是小鼠的天然病原体,与人类的遗传和病理相似。疱疹病毒Epstein-Barr病毒和卡波西肉瘤疱疹病毒。IFN在MHV 68潜伏期的作用并不需要最充分表征的IFN刺激的抗病毒基因,这促使我们考虑一种新的机制。事实上,我们的初步数据表明,IFN直接调节MHV 68潜伏基因的表达,通过结合细胞干扰素调节因子(IRF)的病毒启动子在潜伏感染的B细胞。这表明了一个有趣的假设,疱疹病毒已经进化到整合其基因表达电路与IFN信号通路,从而选择宿主抗病毒系统,以促进免疫妥协期间的战略时机的重新激活。拟议的研究使用易处理的MHV 68系统,以确定IFN在体内调节病毒潜伏基因表达和再激活的生理作用。提出了三个特定目的:(i)检验IFN通过在潜伏期直接作用于感染细胞来调节MHV 68感染的假设;(ii)鉴定控制复制、基因表达和再活化的干扰素调节的病毒启动子元件;(iii)定义IRF调节潜伏病毒基因表达和再活化的机制。这项研究对于了解IFN在慢性感染中的功能具有广泛的意义,并将导致识别宿主抗病毒途径,这些途径可能被证明与控制致癌的人类肿瘤相关。疱疹病毒
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality.
γ掌病毒与干扰素 - α/β诱导的IRF2合作,以停止病毒复制,控制重新激活并最大程度地减少宿主致死性。
- DOI:10.1371/journal.ppat.1002371
- 发表时间:2011-11
- 期刊:
- 影响因子:6.7
- 作者:Mandal P;Krueger BE;Oldenburg D;Andry KA;Beard RS;White DW;Barton ES
- 通讯作者:Barton ES
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON Mitchell GRAYSON其他文献
JASON Mitchell GRAYSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON Mitchell GRAYSON', 18)}}的其他基金
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
重新利用药物抑制人类 T 细胞和自身免疫
- 批准号:
8889627 - 财政年份:2014
- 资助金额:
$ 36.63万 - 项目类别:
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
重新利用药物抑制人类 T 细胞和自身免疫
- 批准号:
8771735 - 财政年份:2014
- 资助金额:
$ 36.63万 - 项目类别:
Mechanisms of CD8+ T Cell Apoptosis During Acute and Chronic Viral Infections
急慢性病毒感染过程中CD8 T细胞凋亡机制
- 批准号:
8018876 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
8240546 - 财政年份:2008
- 资助金额:
$ 36.63万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7556319 - 财政年份:2008
- 资助金额:
$ 36.63万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7783793 - 财政年份:2008
- 资助金额:
$ 36.63万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7464853 - 财政年份:2008
- 资助金额:
$ 36.63万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
8034740 - 财政年份:2008
- 资助金额:
$ 36.63万 - 项目类别:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
V 期间抗原特异性淋巴细胞的基因表达
- 批准号:
6372894 - 财政年份:2001
- 资助金额:
$ 36.63万 - 项目类别:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
V 期间抗原特异性淋巴细胞的基因表达
- 批准号:
6169102 - 财政年份:2000
- 资助金额:
$ 36.63万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Research Grant














{{item.name}}会员




